T 2680/19 (Alpha-1 antitrypsin for subcutaneous administration/GRIFOLS THERAPEUTICS) of 05.05.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T268019.20220505
- Date of decision
- 5 May 2022
- Case number
- T 2680/19
- Petition for review of
- -
- Application number
- 08845718.9
- IPC class
- C07K 14/81A61K 38/47A61K 38/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method, composition, and article of manufacture for providing alpha-1 antitrypsin
- Applicant name
- Grifols Therapeutics Inc.
- Opponent name
- CSL Behring GmbH
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention R 103(4)(a)
- Keywords
- Auxiliary requests 1 to 6 - amendments allowable (no)
Reimbursement of appeal fee - withdrawal of appeal - Catchword
- -
- Cited cases
- G 0002/10
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.